Olympus Releases Visera Elite III Surgical Imaging Platform in U.S.

Olympus has rolled out its Visera Elite III surgical imaging platform in the U.S. The Visera Elite III platform is the third major co-developed product by SONY Olympus Medical (SOMED), a joint venture that was established in 2013.

The platform integrates advanced imaging technologies into a software-driven platform that supports minimally invasive surgery in a variety of specialties. Advanced features include True 4K and 3D imaging, Continuous Auto Focus (CAF), Narrow Band Imaging (NBI) technology, Yellow Enhancement (YE), ENDOEYE rigid and flexible videoscopes, and Fluorescence-Guided Surgery (IR/ICG)—now in full 4K White Light and high contrast Magenta Mode.

Visera Elite III supports specialties including arthroscopy, colorectal, ENT, bariatric, thoracic, gynecological, urological, HPB transplant and general surgery.

Olympus said eight out of ten surgeons surveyed last year agreed that Yellow Enhancement can assist in identifying vessels, nerves, and critical structures within adipose tissue. The company also said that 3D imaging with horizon lock reduces surgical suturing time when compared to 2D imaging and can boost laparoscopic visualization.

IR/ICG imaging provides visualization for perfusion assessment and resection margin accuracy, potentially reducing anastomotic leak rates. The platform can stream clinical and room video, automate workflows, and allow EHR integration with video capture and documentation through Olympus’ VaultStream and LiveStream portals.

“VISERA ELITE III is more than a platform—it’s a strategic enabler for modern operating rooms and is a cornerstone of Olympus’ SEE. TREAT. CONNECT. ecosystem,” said Darryl Rock, VP and Surgical Solutions regional business lead at Olympus Corporation of the Americas. “Its software-based architecture allows hospitals to scale capabilities while controlling capital investment and selectively activate advanced features like 3D and infrared imaging as needed. By seamlessly integrating data into electronic health records and IT systems, VISERA ELITE III may facilitate flexibility and clinical workflow and enable clinicians to focus on what matters most—delivering high-quality care while optimizing their investment.”

Last month, the company released study results showing its CADDIE artificial intelligence (AI) solution helps detect high-risk and hard-to-detect colorectal lesions.